Intravenous Immunoglobulin (IVIG) is a crucial treatment option for individuals with immune system deficiencies and certain autoimmune disorders. This therapy involves the infusion of antibodies derived from healthy donors, which helps boost the immune response and provides essential protection against infections. IVIG is often used to treat conditions such as primary immunodeficiency diseases, Guillain-Barré syndrome, and chronic inflammatory demyelinating polyneuropathy.

The treatment is typically administered in a clinical setting, allowing for careful monitoring of patients for potential side effects, such as headaches or allergic reactions. Beyond its therapeutic benefits, IVIG has been shown to improve overall quality of life for many patients, making it a vital component of modern immunological care.